ImetelChat

In the ASH disclosures, I see that Dr P, who will be flying from Europe to be the presenter of the poster at ASH, is a Consultant for Novartis, a Consultant for Celgene, and a Consultant for Abbvie.

Rest assured these trials are in good hands and have the interest of large biopharmas.

Ryan, thanks for posting. Good point. Interesting that the primary presenter is European and the big news clinical news seems to find its way to EHA over ASH. bp